Description: Avidity Biosciences, Inc. engages in the research and development of biopharmaceutical products. It develops Nano-Medicine Platform that provides nano-medicines for the treatment of cancer and other diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.
Home Page: www.aviditybiosciences.com
RNA Technical Analysis
10578 Science Center Drive
San Diego,
CA
92121
United States
Phone:
858 401 7900
Officers
| Name | Title |
|---|---|
| Dr. Troy Edward Wilson J.D., Ph.D. | Co-Founder & Chairman |
| Ms. Sarah Boyce | Pres, CEO & Director |
| Mr. Michael F. MacLean | Chief Financial & Bus. Officer |
| Dr. W. Michael Flanagan Ph.D. | Chief Technical Officer |
| Dr. Arthur A. Levin Ph.D. | Chief Scientific Officer |
| Prof. Mark E. Davis | Scientific Founder, Member of Scientific Advisory Board and Member of Board of Mang.s |
| Dr. Frank McCormick Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
| Ms. Kathleen Gallagher | Sr. VP of Corp. Communications & Investor Relations |
| Dr. John W. Wallen III | VP of Intellectual Property, Gen. Counsel & Sec. |
| Ms. Teresa McCarthy | Chief HR Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.5762 |
| Price-to-Sales TTM: | 118.9953 |
| IPO Date: | 2013-06-28 |
| Fiscal Year End: | December |
| Full Time Employees: | 125 |